Matrix metalloproteinase-8 in sera and from polymorphonuclear leucocytes in rheumatoid arthritis: In vitro characterization and correlation with disease activity

Clinical and Experimental Rheumatology

Volumn 22, Issue 5, 2004, Pages 597-602

  Rajasekhar, Liza ^a,b   Liou, Lich Bang ^a   Chan, C Y ^a   Tsai, W P ^a   Cheng, C Y ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cytokines; Immune complexes; Matrix metalloproteinase 8; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 15; INTERLEUKIN 18; NEUTROPHIL COLLAGENASE; PHORBOL 13 ACETATE 12 MYRISTATE; RABBIT ANTISERUM;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD LEVEL; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SUPERNATANT;

ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-15; INTERLEUKIN-18; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; TETRADECANOYLPHORBOL ACETATE;

EID: 4644258664     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. YAMANISHI Y, FIRESTEIN GS: Pathogenesis of rheumatoid arthritis. The role of synoviocytes. Rheum Dis Clin North Am 2000; 27: 355-71.
2. BORREGAARD N, COWLAND JB: Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89: 3503-21.
3. OHNO O, COOKE TD: Electron microscopic morphology of immunoglobulin aggregates and their interactions in rheumatoid articular collagenous tissues. Arthritis Rheum 1978; 21: 516-27.
4. ZVAIFLER NJ: Rheumatoid synovitis. An extravascular immune complex disease. Arthritis Rheum 1974; 17: 297-305.
5. VOICE JK, LACHMANN PJ: Neutrophil Fc gamma and complement receptors involved in binding Soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes. Eur J Immunol 1997; 27: 2514-23.
6. LAMBERT PH et al.: Immune complexes and complement activation in rheumatoid arthritis. Proceedings of the Symposium on Immunology and Infection in the Rheumatic Diseases. London, Blackwell and Co. Ltd. 1974.
7. McINNES IB, AL-MUGHALES J, FIELD M, LEUNG BP, HUANG FP, DIXON R: The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996; 2: 175-82.
8. GRACIE JA, FORSEY RJ, CHAN WL et al.: A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104: 1393-401.
9. GIRARD D, PAQUET ME, PAQUIN R, BEAULIEU AD: Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood 1996; 88: 3176-84.
10. McDONALD PP, RUSSO MP, FERRINI S, CASSATELLA MA: Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils. Blood 1998; 92: 4828-35.
11. LI F, GORDON JR: IL-8 ((3-73))K11R is a high affinity agonist of the neutrophil CXCR1 and CXCR2. Biochem Biophy Res Commun 2001; 24: 595-600.
12. McINNES IB, GRACIE JA, LIEW FY: Interleukin-18: A novel cytokine in inflammatory rheumatic disease. Arthritis Rheum 2001; 44 (7): 1481-83.
13. LEUNG P, CULSHAW S, GRACIE JA et al.: A role for IL-18 in neutrophil activation. J Immunol 2001; 167: 2879-86.
14. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
15. FELSON DT, ANDERSON JJ, BOERS M et al.: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 729-40.
16. LIOU LB: Serum and in vitro production of IL-1 receptor antagonist correlate with serum CRP levels in newly diagnosed, untreated patients with systemic lupus erythematosus. Clin Exp Rheumatol 2001; 19: 515-23.
17. HANAMAAIJER R, SORSA T, KONTTINEN YT et al.: Matrix Metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline. J Biol Chem 1997; 272: 31504-9.
18. SHLOPOV BV, LIE WR, MAINARDI CL, COLE AA, CHUBINSKAYA S, HAST KA: Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997; 40: 2065-74.
19. TEEKING JL, DE GROOT ER, EERENBERG AJ, BLEEKER WK, VAN MIERLO G, AARDEN LA et al.: Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro. Clin Exp Immunol 1998; 114: 264-70.
20. CHATHAM WW, HECK LW, BLACKBURN WD Jr: Ligand-dependent release of active neutrophil collagenase. Arthritis Rheum 1990; 33: 228-34.